webinar register page

Webinar banner
Cervical Cancer Screening in 2022: Why Co-Testing is Essential for Patient-Centered Care
Please join us as the CEO of the American Society for Clinical Pathology, Blair Holladay, PhD, MASCP, SCT (ASCP) CM, moderates a roundtable discussion on cervical cancer screening strategy in the United States. Dr. Holladay and a multi-disciplinary panel of experts featuring cytopathologists and OB/GYNs will use patient case-based reviews to address the following topics:

1. Proven benefits of co-testing (Pap + hrHPV) for detection of pre-cancers and cancers

2. Impact of new screening guidelines on women’s health and patient care

3. Strategies for further reducing cervical cancer in populations who experience healthcare inequities

4. Role of healthcare providers, pathology and laboratory medicine in patient support and education

Speakers include:

• Blair Holladay, PhD, MASCP, SCT (ASCP) CM, - CEO, American Society for Clinical Pathology

• Darren Wheeler, MD - Regional Medical Director of Anatomic Pathology, Quest Diagnostics

• Adrienne Stevenson, MD - OBGYN

• Amitasrigowri S. Murthy, MD, MPH, FACOG - OB/GYN, City Medical Specialist, Bureau of Maternal, Infant and Reproductive Health, New York City Department of Health and Mental Hygiene

• Diane D. Davey, MD - Associate Dean, Graduate Medical Education, Professor of Pathology at University of Central Florida

Jan 26, 2022 07:00 PM in Eastern Time (US and Canada)

* Required information
Loading

Speakers

Blair Holladay, PhD, MASCP, SCT (ASCP) CM
CEO, American Society for Clinical Pathology
Darren Wheeler, MD
Regional Medical Director of Anatomic Pathology, Quest Diagnostics
Adrienne Stevenson, MD
OBGYN
Amitasrigowri S. Murthy, MD, MPH, FACOG
OB/GYN, City Medical Specialist, Bureau of Maternal, Infant and Reproductive Health, New York City Department of Health and Mental Hygiene
Diane D. Davey, MD
Associate Dean, Graduate Medical Education, Professor of Pathology at University of Central Florida